FDA Import Refusal SCS-2547419-9/11/1 — Glaxo Wellcome S.A.
The FDA refused shipment SCS-2547419-9/11/1 from Glaxo Wellcome S.A. (Spain) on Jan 30, 2019. The refused product falls under Drugs and Biologics — BRONCHODILATOR N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 30, 2019
- Country
- Spain
- Product Category
- Drugs and Biologics
- Product Code
- 63BCY99 BRONCHODILATOR N.E.C.
- Charges
- 75